Try our Advanced Search for more refined results
May 31, 2017
Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd. et al
Case Number:
1:17-cv-11008
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Barnes & Thornburg
- Burns & Levinson
- Fish & Richardson
- Fox Rothschild
- Haug Partners
- Kirkland & Ellis
- Leydig Voit
- Nutter McClennen
- Patterson Belknap
- Winston & Strawn
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 31, 2018
Janssen Loses Remicade Patent Case To Pfizer, Celltrion
A recipe related to Janssen Biotech Inc.'s blockbuster immunosuppressant Remicade was too obvious for any competitor to have legally infringed a patent on it, a Massachusetts federal judge ruled Tuesday, allowing Pfizer Inc. to rest easy about the validity of its new-to-market equivalent to treat arthritis and psoriasis among other common conditions.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login